Blueprint Medicines Corp (BPMC)
94.15
-2.47
(-2.56%)
USD |
NASDAQ |
Nov 22, 16:00
94.20
+0.05
(+0.05%)
After-Hours: 20:00
Blueprint Medicines Price: 94.15 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 96.78 | 98.34 | 94.11 | 94.15 | 663534.0 |
Nov 21, 2024 | 94.98 | 98.13 | 92.97 | 96.62 | 778933.0 |
Nov 20, 2024 | 94.16 | 95.02 | 92.66 | 94.81 | 566224.0 |
Nov 19, 2024 | 89.69 | 95.48 | 88.97 | 94.60 | 779124.0 |
Nov 18, 2024 | 88.43 | 90.66 | 88.05 | 90.18 | 628452.0 |
Nov 15, 2024 | 96.34 | 96.34 | 88.41 | 88.69 | 1.001M |
Nov 14, 2024 | 99.18 | 100.01 | 95.46 | 95.65 | 471836.0 |
Nov 13, 2024 | 98.00 | 100.23 | 96.83 | 96.88 | 366306.0 |
Nov 12, 2024 | 98.60 | 100.85 | 96.52 | 96.62 | 452582.0 |
Nov 11, 2024 | 102.07 | 103.55 | 99.40 | 99.87 | 455299.0 |
Nov 08, 2024 | 101.58 | 101.97 | 98.95 | 100.83 | 625068.0 |
Nov 07, 2024 | 99.33 | 102.46 | 98.59 | 101.39 | 697909.0 |
Nov 06, 2024 | 100.00 | 101.48 | 98.40 | 99.63 | 965355.0 |
Nov 05, 2024 | 91.00 | 97.66 | 91.00 | 97.55 | 939108.0 |
Nov 04, 2024 | 90.70 | 93.00 | 89.50 | 91.88 | 580584.0 |
Nov 01, 2024 | 87.53 | 90.85 | 87.28 | 90.70 | 619676.0 |
Oct 31, 2024 | 89.23 | 89.61 | 87.31 | 87.51 | 834973.0 |
Oct 30, 2024 | 90.92 | 94.98 | 88.80 | 89.24 | 1.914M |
Oct 29, 2024 | 82.67 | 83.48 | 80.68 | 83.40 | 1.194M |
Oct 28, 2024 | 83.33 | 84.64 | 81.67 | 82.77 | 633915.0 |
Oct 25, 2024 | 83.08 | 83.65 | 82.36 | 82.47 | 423848.0 |
Oct 24, 2024 | 84.56 | 84.56 | 81.22 | 83.09 | 679648.0 |
Oct 23, 2024 | 86.47 | 86.69 | 83.59 | 84.40 | 434971.0 |
Oct 22, 2024 | 85.00 | 87.24 | 84.09 | 86.47 | 758496.0 |
Oct 21, 2024 | 85.78 | 86.12 | 84.03 | 85.61 | 653880.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.97
Minimum
Feb 24 2023
124.48
Maximum
Dec 23 2020
76.81
Average
77.02
Median
Price Benchmarks
Biomarin Pharmaceutical Inc | 64.26 |
Regeneron Pharmaceuticals Inc | 738.00 |
NovaBay Pharmaceuticals Inc | 0.681 |
Palatin Technologies Inc | 0.96 |
iBio Inc | 2.64 |
Price Related Metrics
PS Ratio | 13.60 |
Price to Book Value | 19.10 |
Earnings Yield | -2.24% |
Market Cap | 5.981B |